Medical Oncologist
Treatment options
Does removing the healthy breast improve survival?
Many women assume removing both breasts means a longer life. For most women with cancer in one breast, studies have not shown this, because survival depends mainly on the cancer already diagnosed. This page explains why, which high-risk groups may differ, the limits of the evidence and what does improve outcomes.
MM
Medically reviewed by Dr. Muralidhar MuddusettyConsultant Surgical Oncologist · MBBS (AIIMS), MS (Surgery, AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Does removing the healthy breast help you live longer?
- Four reasons survival rarely changes
- What the evidence generally suggests
- The vocabulary, in plain language
- Honest realities about the evidence
- Steps that do improve outcomes
- Questions to ask your team
- What people assume about survival and removing the other breast
- Common questions about survival and removing the healthy breast
The short answer
Does removing the healthy breast help you live longer?
For most women with breast cancer in one breast, removing the other, healthy breast has not been shown to improve survival. This can be surprising, because it seems logical that removing more breast tissue should mean more protection. The explanation lies in what actually shapes survival after breast cancer. The main threat is the cancer you already have spreading to other parts of the body, such as the bones, liver or lungs. Removing the other breast does nothing to lower that risk. What it does lower is the chance of a new, separate cancer developing in the other breast. For women without a high-risk gene change, that chance is usually low, and it is reduced further by hormone therapy and chemotherapy that many women already receive. Even if a new cancer does appear, regular screening often finds it early, when it is usually very treatable. So, across large groups of average-risk women, the extra surgery prevents relatively few cancers and makes little or no difference to how long women live. The picture changes for women who carry a harmful BRCA1 or BRCA2 change, and possibly for those diagnosed very young, where the chance of a second cancer is much higher. Some studies in these groups suggest a possible survival benefit, although the evidence is not perfect. For them, the discussion is more finely balanced and worth having in detail.
Survival depends mainly on the first cancer
Spread of the known cancer, not a new cancer in the other breast, drives most outcomes.
Average-risk women usually gain little
Studies generally show no clear survival advantage for this group.
High-risk women may be different
BRCA carriers and some young women may gain more, and deserve a detailed discussion.
This page gives general information only. Your oncology team can explain what the evidence means for you.Why this happens
Four reasons survival rarely changes
Understanding these reasons can make the evidence feel less confusing.
The first cancer matters most
The chance of the known cancer returning or spreading is usually higher than the chance of a new cancer in the other breast.
New cancers are uncommon
For most women without a high-risk gene, a new cancer in the other breast develops in only a small minority over many years.
Your own risk can be estimated by your team.Treatment protects both sides
Hormone therapy and chemotherapy lower the chance of a new cancer in the other breast.
Screening finds cancers early
Regular imaging aims to catch any new cancer while it is small.
Early-found cancers are often
- Smaller
- Less likely to have spread
- Treatable with less extensive care
By situation
What the evidence generally suggests
Group
General picture on survival
Average-risk women
No clear survival benefit shown
BRCA1 or BRCA2 carriers
Some studies suggest a possible benefit, particularly with younger age at diagnosis
Very young women without a gene change
Evidence is limited and mixed
Women with advanced or spread cancer
Unlikely to benefit, as survival is shaped by the existing cancer
Older women
Benefit is generally smaller, as fewer years of risk remain
Not sure whether this applies to you?
Ask an oncologistWords you may hear
The vocabulary, in plain language
- Overall survival
- How long people live after diagnosis, from any cause.
- Breast cancer-specific survival
- How long people live without dying from breast cancer.
- Observational study
- Research that watches what happens to people who made different choices, rather than assigning them.
- Selection bias
- When people who choose a treatment differ in ways that affect results, such as being healthier.
- Contralateral breast cancer
- A new cancer in the other breast.
- Distant recurrence
- The original cancer returning in other parts of the body.
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Being straight with you
Honest realities about the evidence
The research on this question has real limits that are worth knowing.
There are no large randomised trials
Most evidence comes from observational studies, which cannot fully separate the effect of surgery from other factors.
Healthier women may choose surgery
Women who opt for more surgery are often younger and healthier, which can make surgery look better than it is.
Treatments keep improving
Older studies may not reflect current hormone therapy, chemotherapy and screening.
Survival is not the only outcome
Peace of mind, body image and quality of life also matter to many women.
What this page cannot tell you
It cannot predict your own survival. Your oncologist can discuss your cancer's features and likely outcomes.
What does help
Steps that do improve outcomes
If your aim is to live as long and as well as possible, these parts of care make the biggest difference.
Complete recommended treatment
Surgery, radiotherapy, chemotherapy, HER2-targeted treatment and hormone therapy each lower the chance of the cancer returning.
Keep taking hormone tablets
For hormone-sensitive cancer, continuing hormone therapy for the full recommended time is especially important.
Attend follow-up
Regular checks and imaging find problems early.
Report new symptoms
Persistent bone pain, breathlessness, a new lump or unexplained weight loss should be checked promptly.
Look after your general health
Regular activity, a healthy weight and not smoking support overall wellbeing after cancer.
At your appointment
Questions to ask your team
These questions help turn general evidence into advice for your situation.
What is my risk of the first cancer returning?
Understanding this puts the risk of a new cancer in context.
What is my risk of a new cancer in the other breast?
Ask for an estimate over the next ten years in plain numbers.
Should I have genetic testing?
A gene result can change the balance of benefit considerably.
What would surgery add to my recovery?
Ask whether two-sided surgery could delay other treatment you need.
Commonly believed
What people assume about survival and removing the other breast
More surgery always means longer life.
For most women, removing the healthy breast does not improve survival.
Cancer usually moves to the other breast.
Spread usually goes to bones, liver or lungs; a cancer in the other breast is usually new.
Women who remove both breasts live longer, so it must work.
These women are often younger and healthier, which affects the comparison.
If it does not improve survival, it is pointless.
Some high-risk women benefit, and peace of mind matters to some.
Questions we are asked
Common questions about survival and removing the healthy breast
Why do some studies show better survival with double mastectomy?
Women who choose to remove both breasts are often younger, healthier, and have better access to care. These differences can make survival look better, even if the surgery itself is not the cause. When studies adjust for these factors, the apparent benefit usually shrinks or disappears.
Does it help if I am a BRCA carrier?
For BRCA carriers, the chance of a new cancer in the other breast is much higher, and some studies suggest removing it may improve survival, especially when diagnosed younger. The benefit depends on the gene, your age and the features of your first cancer, so discuss it in detail with your team.
What if my first cancer was triple-negative?
Triple-negative cancer is linked with BRCA1 changes, so genetic testing is often advised. Without a gene change, survival is mainly shaped by the first cancer's response to treatment, and removing the other breast is unlikely to change that. With a gene change, the discussion differs.
Is it wrong to want it even if survival does not improve?
No. Your feelings are valid, and some women value peace of mind or symmetry highly. It is important, though, to understand the extra risks and that worry about recurrence may continue. Talking it through with your surgeon and a counsellor helps you make a choice you are comfortable with.
Will hormone therapy protect my other breast?
For hormone-sensitive cancers, hormone therapy lowers the chance of the first cancer returning and also reduces the chance of a new cancer in the other breast. This is one reason the extra benefit of surgery is small for many women.
Can a second cancer be found early enough with screening?
Regular mammograms, and sometimes MRI, aim to find new cancers early, when they are usually small and very treatable. Screening is not perfect, and a few cancers are found between scans. Report any changes you notice between appointments.
Does my age change the answer?
Younger women have more years ahead in which a new cancer could develop, so any benefit tends to be greater. Older women have fewer years of risk remaining and may face higher surgical risks, so the benefit is usually smaller.
Can I decide after finishing treatment?
Yes. There is rarely a medical need to decide at diagnosis. Waiting lets you get genetic results, focus on treating the known cancer and make the decision with a clearer mind. Surgery on the other breast can be done later if you still want it.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Warangal
Vizag
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Sources
- National Cancer Institute — Surgery to reduce the risk of breast cancer
- American Society of Breast Surgeons — Position statement on contralateral mastectomy
- American Cancer Society — Preventive surgery to reduce breast cancer risk
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.